Dose–response curves showing the effect of GSK461364A on the viability of a panel of ATC and PDTC cell lines (mouse cell lines: T1860, T1903, T683, T826; human cell lines: Cal62, C643, ACT-1, OCUT-2, 8505-C, THJ16T). PDTC, poorly differentiated thyroid carcinoma.